Top Medical News
Roshini Claire Anthony, 20 hours ago

Survivors of Hodgkin lymphoma (HL) have a twofold risk of developing a second cancer, with a higher risk among those with a family history of cancer, a recent study found.

2 days ago
Both the American Thyroid Association (ATA) paediatric risk classification and dynamic risk stratification (DRS) based on the response to initial therapy appear to be useful in predicting recurrent or persistent disease in paediatric patients with differentiated thyroid cancer (DTC), suggest a recent study.
Jairia Dela Cruz, 3 days ago
The conventional cisplatin–capecitabine-based definitive chemoradiotherapy appears to be an effective treatment option in patients with oesophageal cancer, providing excellent survival benefit with a low long-term toxicity, according to a mature analysis of the SCOPE-1 study.
Christina Lau, 3 days ago

Stereotatic body radiation therapy (SBRT) can effectively and safely extend survival of patients in their 80s and 90s with early-stage lung cancer, according to results of a small study presented at the 2017 Multidisciplinary Thoracic Cancers Symposium in San Francisco, California, US.

3 days ago
Patients with chronic obstructive pulmonary disease (COPD) are at a higher risk of developing cancers, a new observational study shows.
Elvira Manzano, 3 days ago
There is insufficient evidence to assess the harms and benefits of using pelvic examinations to screen for gynaecologic conditions in asymptomatic nonpregnant adult women, according to a recommendation statement issued by the US Preventive Services Task Force (USPSTF).
Dr. Angela V. Ignacio, 4 days ago
Among breast cancer survivors, engaging in high levels of physical activity before or around the time of diagnosis may decrease the risk of developing cardiovascular events (CVE) and dying from coronary heart disease (CHD) after receiving cancer therapy, according to a study presented at the American College of Cardiology’s 66th Annual Scientific Session in Washington, DC.
Special Reports
14 Mar 2017
Over 20 leading surgical and medical oncologists from Singapore attended a dinner meeting on the Neoadjuvant treatment of early breast cancer (eBC). Co-chaired by Dr Veronique Tan (National Cancer Centre, Singapore) and Dr Elaine Lim (National Cancer Centre, Singapore), the meeting served as a platform to discuss the role of neoadjuvant therapy in eBC management. Guest speakers, Professor J. Michael Dixon OBE (Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom) and Dr Rebecca Dent (National Cancer Centre, Singapore) shared their perspectives on the benefits of neoadjuvant therapy in different BC subtypes.
31 Jan 2017
At the launch of Caris Molecular Intelligence® in Malaysia, Dr Andrew Dean, Head of Oncology at the St John of God Subianco Hospital, Perth, shared with the audience on molecular profiling and its benefits, with a focus on the Caris Molecular Intelligence® service.
16 Dec 2016
KEYTRUDA – Pembrolizumab 100 mg/4 mL soln for inj – Merck Sharp & Dohme
Yao-Hua Law, PhD, 15 Dec 2016
The genomics of cancer patients affect their responses to therapies. Some genomic alterations in cancer genes are better treated with targeted therapies, and physicians informed by genomic profiles of their patients can better decide on optimal treatments. Next-generation sequencing (NGS) technology has facilitated rapid and inexpensive gene sequencing for clinical use. This article discusses NGS applications for cancer management, focusing on comprehensive genomic profiling (CGP).
Jairia Dela Cruz, 06 Dec 2016
Sorafenib appears to be well-tolerated in patients with hepatocellular carcinoma (HCC), with the subgroup of Child-Pugh B patients having a shorter treatment duration and higher serious adverse event (SAE) incidence, according to the results of a subgroup analysis of GIDEON*.
Pearl Toh, 29 Nov 2016
New-generation therapies targeted toward specific genetic alterations such as EGFR and ALK mutations in non-small cell lung cancer (NSCLC) can overcome resistance to first-generation therapies and improve survival of patients, according to a presentation at the 21st Congress of the Asian Pacific Society of Respirology (APSR 2016) held in Bangkok, Thailand.
Dr. Rose Zhao-Wei Ting, 16 Nov 2016
A 55-year-old man presented with almost one year history of heat intolerance, mild palpitation and significant weight loss. Free T3 and T4 were elevated with normal TSH. Patient had suboptimal response to carbimazole therapy.
Conference Reports
Dr. Angela V. Ignacio, 20 Mar 2017
Among breast cancer survivors, engaging in high levels of physical activity before or around the time of diagnosis may decrease the risk of developing cardiovascular events (CVE) and dying from coronary heart disease (CHD) after receiving cancer therapy, according to a study presented at the American College of Cardiology’s 66th Annual Scientific Session in Washington, DC.
Pearl Toh, 13 Mar 2017
Pearl Toh finds out from Professor Anna Lok, director of clinical hepatology at the University of Michigan in Ann Arbor, Michigan, US, on integrating guidelines, research data, and clinical setting in decision making for management of hepatitis B during the recent Asian Pacific Association for the Study of the Liver Annual Meeting held in Shanghai, China.

28 Feb 2017
Slideshow: Highlights from the 7th Association of South-East Asian Pain Societies (ASEAPS) Congress 2017
Tristan Manalac, 25 Feb 2017
Compared with viral hepatocellular carcinomas and those of other aetiologies, cryptogenic hepatocellular carcinomas tend to manifest at later stages and are associated with worse survival, according to a study presented at the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL 2017).
24 Feb 2017
Slideshow: Highlights from the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Shanghai, China, February 15 - 19.
Jackey Suen, 24 Feb 2017

Research on the role of circulating tumour DNA (ctDNA) in metastatic castration-resistant prostate cancer (mCRPC) gains momentum, as a new study finds ctDNA assessment promising in the monitoring and prognosis of mCRPC and in identifying new therapeutic targets for the disease.

Roshini Claire Anthony, 22 Feb 2017

Individuals with hepatitis C virus (HCV) infection who achieve a sustained virological response (SVR) have improved liver stiffness and a lower risk of hepatocellular carcinoma (HCC), according to a presentation at the Asian Pacific Association for the Study of the Liver annual meeting (APASL 2017) in Shanghai, China.

Product Highlights
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
DOWNLOAD